{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:55Z","timestamp":1793414155019,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,6]]},"abstract":"<jats:p>Three reports address the protection of the vulnerable population of patients with hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest that some patients who fail to mount a B-cell response to vaccine may nevertheless have protective T cell responses. As a group, these reports suggest that patients should continue to be immunized with additional doses to attempt to improve immune response but that they need to maintain the precautions recommended for the unvaccinated.<\/jats:p>","DOI":"10.1182\/blood.2021013429","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T19:41:41Z","timestamp":1634758901000},"page":"137-142","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma"],"prefix":"10.1182","volume":"139","author":[{"given":"Julius C.","family":"En\u00dfle","sequence":"first","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-9697","authenticated-orcid":false,"given":"Julia","family":"Campe","sequence":"additional","affiliation":[{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Division of Pediatric Stem Cell Transplantation and Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Schwenger","sequence":"additional","affiliation":[{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Division of Pediatric Stem Cell Transplantation and Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8434-6492","authenticated-orcid":false,"given":"Eliza","family":"Wiercinska","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt am Main, Germany;"},{"name":"German Red Cross Blood Service BaW\u00fcHe, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hellstern","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt am Main, Germany;"},{"name":"German Red Cross Blood Service BaW\u00fcHe, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-0438","authenticated-orcid":false,"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[{"name":"Robert Koch-Institut, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-5872","authenticated-orcid":false,"given":"Michael A.","family":"Rieger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ballo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Steffen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-5516","authenticated-orcid":false,"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-2675","authenticated-orcid":false,"given":"Halvard","family":"Bonig","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt am Main, Germany;"},{"name":"German Red Cross Blood Service BaW\u00fcHe, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger F.","family":"Rabenau","sequence":"additional","affiliation":[{"name":"Insitute for Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-9307","authenticated-orcid":false,"given":"Marek","family":"Widera","sequence":"additional","affiliation":[{"name":"Insitute for Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ciesek","sequence":"additional","affiliation":[{"name":"Insitute for Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; and"},{"name":"German Centre for Infection Research, External partner site, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1699-4313","authenticated-orcid":false,"given":"Ivana von","family":"Metzler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-1192","authenticated-orcid":false,"given":"Evelyn","family":"Ullrich","sequence":"additional","affiliation":[{"name":"Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany;"},{"name":"German Cancer Consortium (DKTK), Heidelberg, Germany;"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"},{"name":"Division of Pediatric Stem Cell Transplantation and Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2022010616202924400_B1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am J Hematol."},{"issue":"1","key":"2022010616202924400_B2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41375-020-01016-0","article-title":"Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network","volume":"35","author":"Ludwig","year":"2021","journal-title":"Leukemia."},{"key":"2022010616202924400_B3","article-title":"COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers","author":"Hultcrantz","year":"2020","journal-title":"medRxiv."},{"key":"2022010616202924400_B4","first-page":"3","article-title":"Hierarchisierung von Risikofaktoren f\u00fcr schwere COVID-19-Erkrankungs-verl\u00e4ufe im Kontext der COVID-19-Schutzimpfungen \u2013 Eine gepoolte GKV-Routinedatenanalyse basierend auf 30 Mio. Versicherten","volume":"19","author":"R\u00f6\u00dfler","year":"2021","journal-title":"Epidemiol Bull."},{"issue":"2","key":"2022010616202924400_B5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/2159-8290.CD-20-1817","article-title":"Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited","volume":"11","author":"Ribas","year":"2021","journal-title":"Cancer Discov."},{"issue":"5","key":"2022010616202924400_B6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41571-021-00487-z","article-title":"COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials [published correction appears in Nat Rev Clin Oncol. 2021;18(5):320]","volume":"18","author":"Desai","year":"2021","journal-title":"Nat Rev Clin Oncol."},{"issue":"4","key":"2022010616202924400_B7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3121\/cmr.3.4.214","article-title":"Efficacy of the influenza vaccine in patients with malignant lymphoma","volume":"3","author":"Mazza","year":"2005","journal-title":"Clin Med Res."},{"key":"2022010616202924400_B8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejca.2021.06.008","article-title":"Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer","volume":"154","author":"Barri\u00e8re","year":"2021","journal-title":"Eur J Cancer."},{"issue":"6","key":"2022010616202924400_B9","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1016\/S2352-3026(21)00110-1","article-title":"Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma","volume":"8","author":"Bird","year":"2021","journal-title":"Lancet Haematol."},{"issue":"8","key":"2022010616202924400_B10","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2352-3026(21)00169-1","article-title":"Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study","volume":"8","author":"Maneikis","year":"2021","journal-title":"Lancet Haematol."},{"issue":"8","key":"2022010616202924400_B11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ccell.2021.06.014","article-title":"Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma","volume":"39","author":"Van Oekelen","year":"2021","journal-title":"Cancer Cell."},{"issue":"1","key":"2022010616202924400_B12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-021-01090-6","article-title":"Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution","volume":"14","author":"Pimpinelli","year":"2021","journal-title":"J Hematol Oncol."},{"issue":"26","key":"2022010616202924400_B13","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1182\/blood.2021011904","article-title":"Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose","volume":"137","author":"Terpos","year":"2021","journal-title":"Blood."},{"issue":"8","key":"2022010616202924400_B14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ccell.2021.06.002","article-title":"Seroconversion rates following COVID-19 vaccination among patients with cancer","volume":"39","author":"Thakkar","year":"2021","journal-title":"Cancer Cell."},{"issue":"7830","key":"2022010616202924400_B15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses [published correction appears in Nature. 2021;590(7844):E17]","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature."},{"issue":"10","key":"2022010616202924400_B16","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.3390\/jcm10102128","article-title":"Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies","volume":"10","author":"Kohmer","year":"2021","journal-title":"J Clin Med."},{"issue":"7","key":"2022010616202924400_B17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med."},{"key":"2022010616202924400_B18","article-title":"COVID-19 in a multiple myeloma patient: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view","author":"Metzler","year":"2021","journal-title":"Res Square"},{"issue":"8","key":"2022010616202924400_B19","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1158\/2159-8290.CD-21-0191","article-title":"Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in patients with cancer","volume":"11","author":"Bilich","year":"2021","journal-title":"Cancer Discov."},{"issue":"7","key":"2022010616202924400_B20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med."},{"issue":"2","key":"2022010616202924400_B21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2021.01.001","article-title":"Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients","volume":"39","author":"Abdul-Jawad","year":"2021","journal-title":"Cancer Cell."},{"issue":"7","key":"2022010616202924400_B22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell."},{"issue":"26","key":"2022010616202924400_B23","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med."},{"issue":"23","key":"2022010616202924400_B24","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med."},{"issue":"7853","key":"2022010616202924400_B25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/1\/137\/1857731\/bloodbld2021013429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/1\/137\/1857731\/bloodbld2021013429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:55:36Z","timestamp":1673571336000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/1\/137\/477351\/Severe-impairment-of-T-cell-responses-to-BNT162b2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021013429","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]}}}